Cargando…

Neuropathology in Mice Expressing Mouse Alpha-Synuclein

α-Synuclein (αSN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (mαSN), which carries a threonine at position 53 like the A53T human mutant version that is...

Descripción completa

Detalles Bibliográficos
Autores principales: Rieker, Claus, Dev, Kumlesh K., Lehnhoff, Katja, Barbieri, Samuel, Ksiazek, Iwona, Kauffmann, Sabine, Danner, Simone, Schell, Heinrich, Boden, Cindy, Ruegg, Markus A., Kahle, Philipp J., van der Putten, Herman, Shimshek, Derya R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180287/
https://www.ncbi.nlm.nih.gov/pubmed/21966373
http://dx.doi.org/10.1371/journal.pone.0024834
_version_ 1782212612129292288
author Rieker, Claus
Dev, Kumlesh K.
Lehnhoff, Katja
Barbieri, Samuel
Ksiazek, Iwona
Kauffmann, Sabine
Danner, Simone
Schell, Heinrich
Boden, Cindy
Ruegg, Markus A.
Kahle, Philipp J.
van der Putten, Herman
Shimshek, Derya R.
author_facet Rieker, Claus
Dev, Kumlesh K.
Lehnhoff, Katja
Barbieri, Samuel
Ksiazek, Iwona
Kauffmann, Sabine
Danner, Simone
Schell, Heinrich
Boden, Cindy
Ruegg, Markus A.
Kahle, Philipp J.
van der Putten, Herman
Shimshek, Derya R.
author_sort Rieker, Claus
collection PubMed
description α-Synuclein (αSN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (mαSN), which carries a threonine at position 53 like the A53T human mutant version that is genetically linked to PD, were never reported. To this end we generated mouse lines that express mαSN in central neurons at levels reaching up to six-fold compared to endogenous mαSN. Unlike transgenic mice expressing human wildtype or mutant forms of αSN, these mαSN transgenic mice showed pronounced ubiquitin immunopathology in spinal cord and brainstem. Isoelectric separation of mαSN species revealed multiple isoforms including two Ser129-phosphorylated species in the most severely affected brain regions. Neuronal Ser129-phosphorylated αSN occured in granular and small fibrillar aggregates and pathological staining patterns in neurites occasionally revealed a striking ladder of small alternating segments staining either for Ser129-phosphorylated αSN or ubiquitin but not both. Axonal degeneration in long white matter tracts of the spinal cord, with breakdown of myelin sheaths and degeneration of neuromuscular junctions with loss of integrity of the presynaptic neurofilament network in mαSN transgenic mice, was similar to what we have reported for mice expressing human αSN wildtype or mutant forms. In hippocampal neurons, the mαSN protein accumulated and was phosphorylated but these neurons showed no ubiquitin immunopathology. In contrast to the early-onset motor abnormalities and muscle weakness observed in mice expressing human αSN, mαSN transgenic mice displayed only end-stage phenotypic alterations that manifested alongside with neuropathology. Altogether these findings show that increased levels of wildtype mαSN does not induce early-onset behavior changes, but drives end-stage pathophysiological changes in murine neurons that are strikingly similar to those evoked by expression of human wildtype or mutant forms.
format Online
Article
Text
id pubmed-3180287
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31802872011-09-30 Neuropathology in Mice Expressing Mouse Alpha-Synuclein Rieker, Claus Dev, Kumlesh K. Lehnhoff, Katja Barbieri, Samuel Ksiazek, Iwona Kauffmann, Sabine Danner, Simone Schell, Heinrich Boden, Cindy Ruegg, Markus A. Kahle, Philipp J. van der Putten, Herman Shimshek, Derya R. PLoS One Research Article α-Synuclein (αSN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (mαSN), which carries a threonine at position 53 like the A53T human mutant version that is genetically linked to PD, were never reported. To this end we generated mouse lines that express mαSN in central neurons at levels reaching up to six-fold compared to endogenous mαSN. Unlike transgenic mice expressing human wildtype or mutant forms of αSN, these mαSN transgenic mice showed pronounced ubiquitin immunopathology in spinal cord and brainstem. Isoelectric separation of mαSN species revealed multiple isoforms including two Ser129-phosphorylated species in the most severely affected brain regions. Neuronal Ser129-phosphorylated αSN occured in granular and small fibrillar aggregates and pathological staining patterns in neurites occasionally revealed a striking ladder of small alternating segments staining either for Ser129-phosphorylated αSN or ubiquitin but not both. Axonal degeneration in long white matter tracts of the spinal cord, with breakdown of myelin sheaths and degeneration of neuromuscular junctions with loss of integrity of the presynaptic neurofilament network in mαSN transgenic mice, was similar to what we have reported for mice expressing human αSN wildtype or mutant forms. In hippocampal neurons, the mαSN protein accumulated and was phosphorylated but these neurons showed no ubiquitin immunopathology. In contrast to the early-onset motor abnormalities and muscle weakness observed in mice expressing human αSN, mαSN transgenic mice displayed only end-stage phenotypic alterations that manifested alongside with neuropathology. Altogether these findings show that increased levels of wildtype mαSN does not induce early-onset behavior changes, but drives end-stage pathophysiological changes in murine neurons that are strikingly similar to those evoked by expression of human wildtype or mutant forms. Public Library of Science 2011-09-26 /pmc/articles/PMC3180287/ /pubmed/21966373 http://dx.doi.org/10.1371/journal.pone.0024834 Text en Rieker et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Rieker, Claus
Dev, Kumlesh K.
Lehnhoff, Katja
Barbieri, Samuel
Ksiazek, Iwona
Kauffmann, Sabine
Danner, Simone
Schell, Heinrich
Boden, Cindy
Ruegg, Markus A.
Kahle, Philipp J.
van der Putten, Herman
Shimshek, Derya R.
Neuropathology in Mice Expressing Mouse Alpha-Synuclein
title Neuropathology in Mice Expressing Mouse Alpha-Synuclein
title_full Neuropathology in Mice Expressing Mouse Alpha-Synuclein
title_fullStr Neuropathology in Mice Expressing Mouse Alpha-Synuclein
title_full_unstemmed Neuropathology in Mice Expressing Mouse Alpha-Synuclein
title_short Neuropathology in Mice Expressing Mouse Alpha-Synuclein
title_sort neuropathology in mice expressing mouse alpha-synuclein
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180287/
https://www.ncbi.nlm.nih.gov/pubmed/21966373
http://dx.doi.org/10.1371/journal.pone.0024834
work_keys_str_mv AT riekerclaus neuropathologyinmiceexpressingmousealphasynuclein
AT devkumleshk neuropathologyinmiceexpressingmousealphasynuclein
AT lehnhoffkatja neuropathologyinmiceexpressingmousealphasynuclein
AT barbierisamuel neuropathologyinmiceexpressingmousealphasynuclein
AT ksiazekiwona neuropathologyinmiceexpressingmousealphasynuclein
AT kauffmannsabine neuropathologyinmiceexpressingmousealphasynuclein
AT dannersimone neuropathologyinmiceexpressingmousealphasynuclein
AT schellheinrich neuropathologyinmiceexpressingmousealphasynuclein
AT bodencindy neuropathologyinmiceexpressingmousealphasynuclein
AT rueggmarkusa neuropathologyinmiceexpressingmousealphasynuclein
AT kahlephilippj neuropathologyinmiceexpressingmousealphasynuclein
AT vanderputtenherman neuropathologyinmiceexpressingmousealphasynuclein
AT shimshekderyar neuropathologyinmiceexpressingmousealphasynuclein